— Know what they know.
Not Investment Advice
Also trades as: 0HV.DE (XETRA) · $vol 0M

NVST NYSE

Envista Holdings Corp
1W: -2.0% 1M: -14.3% 3M: -14.7% YTD: +8.2% 1Y: +15.3% 3Y: -16.1% 5Y: -45.8%
$23.46
+0.30 (+1.30%)
 
Weekly Expected Move ±4.2%
$21 $22 $23 $24 $25
NYSE · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 36 · $3.8B mcap · 162M float · 1.74% daily turnover · Short 64% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$2.7B +8.3% ▲
5Y CAGR: +7.1%
Gross Profit
$1.5B +7.5% ▲
5Y CAGR: +6.9%
Operating Income
$226M +121.7% ▲
5Y CAGR: +39.0%
Net Income
$47M +104.2% ▲
5Y CAGR: +7.1%
EPS (Diluted)
$0.28 +104.3% ▲
5Y CAGR: +1.5%
EBITDA
$342M +22.3% ▲
5Y CAGR: +5.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$2.5B$2.6B$2.6B$2.5B$2.7B
YoY Growth+30.1%+2.4%-0.1%-2.2%+8.3%
Cost of Revenue$1.0B$1.1B$1.1B$1.1B$1.2B
Gross Profit$1.5B$1.5B$1.5B$1.4B$1.5B
Gross Margin58.3%57.9%56.5%55.4%55.0%
R&D Expenses$100M$100M$94M$99M$114M
SG&A Expenses$990M$1.0B$1.0B$1.1B$1.2B
Operating Expenses$1.2B$1.2B$1.4B$2.4B$1.3B
Operating Income$306M$319M$32M-$1.0B$226M
Operating Margin12.2%12.4%1.2%-41.4%8.3%
Interest Expense$54M$38M$63M$46M$37M
Income Before Tax$254M$284M-$55M-$1.1B$177M
Tax Expense-$9M$46M$45M$34M$130M
Net Income$340M$243M-$100M-$1.1B$47M
Net Margin13.6%9.5%-3.9%-44.6%1.7%
EPS (Diluted)$1.48$1.34$-0.60$-6.50$0.28
EBITDA$496M$498M$463M$280M$342M
Shares Outstanding178M178M167M172M169M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms